CBER’s New Director 'Marks' New Era For Biologics Regulation
This article was originally published in The Pink Sheet Daily
Executive Summary
Peter Marks takes over top spot in FDA's center for biologics after four-year training period as deputy director; his background appears well suited to what promises to be a transformative era in medicine.